IPHA Guidance on Direct HealthCare Professional Communication (DHPC)



The Irish Pharmaceutical Healthcare Association (IPHA) has produced a Guidance on Direct Healthcare Professional Communication (DHPC).


The multiple distribution of DHPCs by several companies for the same active ingredient or class effect can decrease the effectiveness of each individual communication. The new guidance sets out a simple, effective framework for companies to work together on a joint DHPC, where a DHPC has been mandated by the regulator and two or more companies are required to distribute the same DHPC,

The Health Products and Regulatory Authority (HPRA) is currently updating its HPRA guide to Marketing Authorisation Holders on DHPCs to reflect the IPHA Guidance, which is effective immediately.





IPHA is a member of -


For medicines and clinical trials information visit -

medicines.ieself-care.ieICTRP Portal